Pancreatic Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 18 years of age or older
- You have been diagnosed with pancreatic cancer (a specific type called adenocarcinoma), confirmed by a biopsy, and your doctors believe surgery to remove the cancer may be possible
- You are willing to have small tissue samples (biopsies) taken from your tumor and nearby normal tissue during your surgery for research purposes
- You either have not received any prior treatment for this cancer, OR you have received at least 3 months of chemotherapy before surgery (the trial is looking for 8 people in each group)
- You are able to understand what the study involves and are willing to sign a consent form before joining
Who may not be able to join:
- You are in the "no prior treatment" group but have already received anti-cancer treatment such as chemotherapy, immunotherapy, or biologic therapy
- You are in the "prior treatment" group but have received radiation therapy, biologic therapy, or immunotherapy before surgery (chemotherapy only is allowed for this group)
- You are currently taking part in, or planning to join, another clinical trial that involves experimental treatments at the same time as this study
- You currently have another active cancer
- You are able to become pregnant and have not recently had a negative pregnancy test done as part of your standard cancer care (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Howard S Hochster, MD, Rutgers Cancer Institute of New Jersey
Phone: 732-235-5912
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
To measure glycolysis metabolism dependencies via liquid chromatography-mass spectrometry (LC-MS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.